Joshua J Gagne

A General Propensity Score for Signal Identification Using Tree-Based Scan Statistics.

Wang SV, Maro JC, Gagne JJ, Patorno E, Kattinakere S, Stojanovic D, Eworuke E, Baro E, Ouellet-Hellstrom R, Nguyen M, Ma Y, Dashevsky I, Cole D, DeLuccia S, Hansbury A, Pestine E, Kulldorff M.

Am J Epidemiol. 2021 07 01. 190(7):1424-1433. PMID: 33615330

Trends in Medicare Part D Inhaler Spending: 2012-2018.

Feldman WB, Gagne JJ, Kesselheim AS.

Ann Am Thorac Soc. 2021 03. 18(3):548-550. PMID: 33207126

Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort study.

Rome BN, Gagne JJ, Avorn J, Kesselheim AS.

Am Heart J. 2021 03. 233:109-121. PMID: 33358690

Drug-Drug Interaction Surveillance Study: Comparing Self-Controlled Designs in Five Empirical Examples in Real-World Data.

Bykov K, Li H, Kim S, Vine SM, Lo Re V, Gagne JJ.

Clin Pharmacol Ther. 2021 05. 109(5):1353-1360. PMID: 33245789

Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity.

Lin KJ, Schneeweiss S, Tesfaye H, D'Andrea E, Liu J, Lii J, Murphy SN, Gagne JJ.

Drugs. 2020 Dec. 80(18):1961-1972. PMID: 33151482

Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.

Gopalakrishnan C, Bykov K, Fischer MA, Connolly JG, Gagne JJ, Fralick M.

JAMA Intern Med. 2020 12 01. 180(12):1596-1605. PMID: 32897307

Using the Case-Crossover Design to Assess Short-Term Risks of Bleeding and Arterial Thromboembolism After Switching Between Oral Anticoagulants in a Population-Based Cohort of Patients With Atrial Fibrillation.

Hellfritzsch M, Wang SV, Grove EL, Gagne JJ, Hallas J, Pottegård A.

Am J Epidemiol. 2020 12 01. 189(12):1467-1477. PMID: 32639512

Empirical assessment of case-based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS).

Thurin NH, Lassalle R, Schuemie M, Pénichon M, Gagne JJ, Rassen JA, Benichou J, Weill A, Blin P, Moore N, Droz-Perroteau C.

Pharmacoepidemiol Drug Saf. 2021 03. 30(3):320-333. PMID: 33099844

Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) Program.

Sarpatwari A, He M, Tessema FA, Gagne JJ, Kesselheim AS.

Drug Saf. 2021 03. 44(3):327-335. PMID: 33206339

Risk of Renal Cell Carcinoma Associated with Calcium Channel Blockers: A Nationwide Observational Study Focusing on Confounding by Indication.

Kristensen KB, Habel LA, Gagne JJ, Friis S, Andersen KK, Hallas J, Pottegård A.

Epidemiology. 2020 11. 31(6):860-871. PMID: 32897909